Cargando…
Hydrogen sulfide therapy in brain diseases: from bench to bedside
Hydrogen sulfide (H(2)S) has been recognized and studied for nearly 300 years, but past researches mainly focus on its toxicity effect. During the past two decades, the majority of researches have reported that H(2)S is a novel endogenous gaseous signal molecule in organisms, and play an important r...
Autores principales: | Zhang, Ju-yi, Ding, Yi-ping, Wang, Zhong, Kong, Yan, Gao, Rong, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510292/ https://www.ncbi.nlm.nih.gov/pubmed/28744364 http://dx.doi.org/10.4103/2045-9912.208517 |
Ejemplares similares
-
Bench-to-bedside review: Hydrogen sulfide – the third gaseous transmitter: applications for critical care
por: Wagner, Florian, et al.
Publicado: (2009) -
Organoids of liver diseases: From bench to bedside
por: Wu, Li-Jun, et al.
Publicado: (2019) -
Therapeutic Potential of Molecular Hydrogen in Metabolic Diseases from Bench to Bedside
por: Xie, Fei, et al.
Publicado: (2023) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022) -
Bench-To-Bedside and Bedside Back to the Bench; Coordinating Clinical and Experimental Traumatic Brain Injury Studies
por: Agoston, Denes V., et al.
Publicado: (2012)